WASHINGTON (Reuters) - A Food and Drug Administration review of CardioMEMS' device for treating heart failure found it has met its main safety and effectiveness goals, based on trial results. But the ... CardioMEMS ran into a regulatory roadblock last week, when an FDA advisory panel recommended that the agency not approve the company's Champion HF Monitoring System.
The device is said to be the first ... Lansing State Journal: Phyllis’s story: How the CardioMEMs device gave her peace of mind There is more than meets the eye when it comes to CardioMEMS and its heart failure monitoring device that St. Jude Medical recently acquired for $375 million. Surgeons implant the smaller-than-a-dime ...
cardiac mems device, FDA reported May 28 it approved the CardioMEMS device, a heart failure remote monitoring device PMA that tanked at an advisory hearing in 2011. The application re-appeared at the circulatory systems ... WASHINGTON, Dec 5 (Reuters) - U.S. health regulators on Monday said a CardioMEMs implant for treating heart failure met its main safety and effectiveness targets but warned of potential bias in the ... MD&M East: How St.
cardiac mems device, Jude Is Buying More Than Just a Heart Failure Device How St. Jude Is Buying More Than Just a Heart Failure Device
